Advertisement
Australia markets open in 4 hours 2 minutes
  • ALL ORDS

    8,020.90
    +25.20 (+0.32%)
     
  • AUD/USD

    0.6693
    +0.0065 (+0.98%)
     
  • ASX 200

    7,753.70
    +26.90 (+0.35%)
     
  • OIL

    78.84
    +0.82 (+1.05%)
     
  • GOLD

    2,392.40
    +32.50 (+1.38%)
     
  • Bitcoin AUD

    98,613.43
    +6,633.47 (+7.21%)
     
  • CMC Crypto 200

    1,394.81
    +126.87 (+10.00%)
     

Bio-Rad’s Management to Participate in Fireside Chat During RBC Capital Markets Global Healthcare Conference

HERCULES, Calif., May 01, 2024--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that its Chief Operating Officer Andy Last and Chief Financial Officer Roop K. Lakkaraju will participate in a fireside chat event during the RBC Capital Markets Global Healthcare Conference on Tuesday, May 14, 2024, at 2:05 PM Eastern Time (11:05 AM Pacific Time).

A live webcast and subsequent replay of the event will be available in the Investor Relations section of Bio-Rad’s website at bio-rad.com.

About Bio-Rad

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B) is a leader in developing, manufacturing, and marketing a broad range of products for the life science research and clinical diagnostics markets. Based in Hercules, California, Bio-Rad operates a global network of research, development, manufacturing, and sales operations with approximately 8,000 employees and $2.7 billion in revenues in 2023. Our customers include universities, research institutions, hospitals, food safety and environmental quality laboratories, and biopharmaceutical companies. Together, we develop innovative, high-quality products that advance science and save lives. To learn more, visit bio-rad.com.

ADVERTISEMENT

View source version on businesswire.com: https://www.businesswire.com/news/home/20240501890301/en/

Contacts

Investor Contact:
Edward Chung, Investor Relations
510-741-6104
ir@bio-rad.com

Media Contact:
Anna Gralinska, Corporate Communications
510-741-6643
cc@bio-rad.com